Metabolic syndrome also associated with higher alanine aminotransferase levels longitudinally
Read More »Monthly Archives: April 2018
April 14, 2018
A couple of days ago we sent out our latest therapy update on SGLT-2 Inhibitors. This class of drugs shows multiple ways to decrease A1c values with a small risk of hypoglycemia. This means that individual glucose levels often are not of concern. This is not true with our insulin-using …
Read More »Prediabetes a Pathway to Heart and Kidney Disease
Individuals with undiagnosed diabetes, prediabetes found to have high incidence of unrecognized chronic kidney disease.
Read More »A1c Crucial Prior to Any Surgery
Study finds higher hospital admissions, complications, and mortality rates among patients with increased A1c.
Read More »Effect of Fenofibrate on Cardiovascular Risk in Type 2 Diabetes
Studies find greater risk reduction following treatment of patients with dyslipidemia.
Read More »Empagliflozin Reduces Cardiovascular Mortality
Most important mediator due to changes in markers of plasma volume.
Read More »Incident Diabetes And Diabetes Treatment in Postmenopausal Women
Secondary analysis evaluates effect of Women’s Health Initiative dietary intervention.
Read More »The Joint is Jumping: CGMS, AI and Wearables
Guest Post by David Kliff, Editor, Diabetic Investor
Senseonics has taken their Eversense implantable CGM before an FDA panel, and Bigfoot has announced they have closed their series B $55 million financing round. The FDA has approved Dexcom’s G6 system, pushing shares in the company higher in early trading. And while they didn’t announce anything recently, our friends at Tandem are feeling the love as shares continue to surge higher in anticipation of their new system, which has low glucose suspend.
Clinical Parameters
Mr. Hernandez's labs are notable for A1C 7.5, FPG 137 mg/dL, LDL-cholesterol 190 mg/dL, HDL-cholesterol 38 mg/dL, and triglycerides 232 mg/dL. You discuss his lab results, his diagnosis, and how to manage diabetes, then you make referrals to the appropriate diabetes team clinicians. You start Mr. Hernandez on metformin, lifestyle modifications, an ACE inhibitor, and a statin. What clinical parameters are you looking to achieve? A. A1C less than 7%, BP less than 130/80 mmHg, LDL less than 100 mg/dL B. A1C less than 7%, BP less than 130/90 mmHg, LDL less than 100 mg/dL C. A1C less than 7%, BP less than 140/80 mmHg, LDL less than 100 mg/dL D. A1C less than 7%, BP less than 140/90 mmHg, LDL less than 150 mg/dL Follow the link for the answer.
Read More »Prescribing Sulfonylureas
Do you prescribe sulfonylureas?
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.